4CMenB Vaccine May Be Nearly 60 Percent Effective Against Meningococcal Group B In Infant Vaccination Program, But Does Not Provide Herd Protection Among Adolescents, Studies Indicate

Healio (2/6, Dreisbach) reports “in separate studies, the capsular group B meningococcal vaccine, or 4CMenB, demonstrated close to 60% effectiveness against meningococcal group B disease in a vaccination program for infants in England, but did not provide...